Advertisement

Recent Updates in The Role of Immunotherapies in NSCLC: Translating Evidence to Clinical Practice - Episode 4

Optimizing the Role of Neoadjuvant Immunotherapy in Resectable NSCLC

Published on: 
, , ,

Drs Vamsidhar Velcheti and Solange Peters discuss the optimum length for immunotherapy treatment in resectable NSCLC, highlighting the issue of payer authorizations.

Advertisement
Advertisement